BioNTech SE – ADR ((BNTX)) is around the middle of the Biotechnology industry according to InvestorsObserver. (BNTX) received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. BioNTech SE – ADR also achieved a score of 47 in the Biotechnology industry, putting it above 47 percent of Biotechnology stocks. Biotechnology is ranked 88 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 39 means the stock is more attractive than 39 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What’s Happening With BioNTech SE – ADR Stock Today?
BioNTech SE – ADR ((BNTX)) stock is trading at $114.50 as of 2:47 PM on Thursday, Apr 8, a rise of $1.18, or 1.04% from the previous closing price of $113.32. The stock has traded between $112.50 and $116.30 so far today. Volume today is below average. So far 797,300 shares have traded compared to average volume of 1,411,188 shares.